Testing effectiveness (Phase 2)Study completedNCT01756989
What this trial is testing
ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors
Who this might be right for
Brainstem Glioma
Helsinki University Central Hospital 50